Humanized recombinant immunotoxin targeting hCG demonstrates therapeutic potential for advanced stage difficult to treat cancers.

MLA

Nain, Kirti, et al. “Humanized Recombinant Immunotoxin Targeting HCG Demonstrates Therapeutic Potential for Advanced Stage Difficult to Treat Cancers.” Journal of Drug Targeting, vol. 33, no. 2, Feb. 2025, pp. 281–94. EBSCOhost, https://doi.org/10.1080/1061186X.2024.2416247.

APA

Nain, K., Sonar, K., Sahoo, S., Gupta, J. C., Grover, S., Arulandu, A., & Talwar, G. P. (2025). Humanized recombinant immunotoxin targeting hCG demonstrates therapeutic potential for advanced stage difficult to treat cancers. Journal of Drug Targeting, 33(2), 281–294. https://doi.org/10.1080/1061186X.2024.2416247

Chicago

Nain, Kirti, Kritika Sonar, Sibasis Sahoo, Jagdish C Gupta, Sonam Grover, Arockiasamy Arulandu, and G P Talwar. 2025. “Humanized Recombinant Immunotoxin Targeting HCG Demonstrates Therapeutic Potential for Advanced Stage Difficult to Treat Cancers.” Journal of Drug Targeting 33 (2): 281–94. doi:10.1080/1061186X.2024.2416247.